Get started
Author

Heather J. Adam

Observed names: Adam, Heather J, Adam, Heather Jill, H Adam, H J Adam, H. Adam, H. J. Adam, H.J. Adam, Heather J. Adam, Heather Adam, Heather J Adam, Heather J. Smith-Adam, Heather J. Smith-adam
Observed institutions: Mount Sinai Hospital, Mount Sinai Health System, Sunnybrook Health Science Centre, Mount Sinai Hospital, University Health Network, Public Health Agency of Canada, University of Toronto, North York General Hospital, Health Sciences Centre, Credit Valley Hospital, Shared Health, Mount Sinai Hospital, University of Manitoba
ORCID: 0000-0002-5646-6454
Observed ORCID: 0000-0002-5646-6454
OpenAlex ID: A5034066865
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
2019 · George G. Zhanel, Alyssa R. Golden, et al. · Drugs · 442
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
2013 · George G. Zhanel, Christopher D. Lawson, et al. · Drugs · 435
Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations
2017 · George G. Zhanel, Courtney K. Lawrence, et al. · Drugs · 378
New Lipoglycopeptides
2010 · George G. Zhanel, Divna Calic, et al. · Drugs · 353
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
2013 · George G. Zhanel, Phillip Chung, et al. · Drugs · 340
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
2016 · George G. Zhanel, Doris Cheung, et al. · Drugs · 317
Identification of Blood Culture Isolates Directly from Positive Blood Cultures by Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and a Commercial Extraction System: Analysis of Performance, Cost, and Turnaround Time
2012 · Philippe R. S. Lagacé-Wiens, Heather J. Adam, et al. · Journal of Clinical Microbiology · 203
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
2012 · George G Zhanel, Christopher D Lawson, et al. · Expert Review of Anti-infective Therapy · 201
Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens
2015 · George G. Zhanel, Riley Love, et al. · Drugs · 187
Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: Evidence for herd effects and strain replacement due to Hib vaccination
2010 · H.J. Adam, S.E. Richardson, et al. · Vaccine · 167
Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2008)
2010 · George G. Zhanel, Melanie DeCorby, et al. · Antimicrobial Agents and Chemotherapy · 166
Molecular epidemiology of extended-spectrum -lactamase-, AmpC -lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11
2013 · A. J. Denisuik, P. R. S. Lagace-Wiens, et al. · Journal of Antimicrobial Chemotherapy · 154
PDF
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study
2013 · G. G. Zhanel, H. J. Adam, et al. · Journal of Antimicrobial Chemotherapy · 148
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent
2020 · George G. Zhanel, Jenine Esquivel, et al. · Drugs · 135
Antimicrobial Resistance in Urinary Tract Pathogens in Canada from 2007 to 2009: CANWARD Surveillance Study
2011 · James A. Karlowsky, Philippe R. S. Lagacé-Wiens, et al. · Antimicrobial Agents and Chemotherapy · 125
PDF
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012
2013 · Walter H.B. Demczuk, Irene Martin, et al. · Canadian Journal of Microbiology · 121
In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012
2014 · A. Walkty, H. Adam, et al. · Antimicrobial Agents and Chemotherapy · 115
Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010-2011: CANWARD Surveillance Study
2011 · James A. Karlowsky, Andrew J. Walkty, et al. · Antimicrobial Agents and Chemotherapy · 109
A Review of New Fluoroquinolones
2006 · George G Zhanel, Sonya Fontaine, et al. · Treatments in Respiratory Medicine · 81
In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone, against 2,440 Clinical Isolates
2009 · Heather J. Adam, Nancy M. Laing, et al. · Antimicrobial Agents and Chemotherapy · 80
Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007–13
2015 · Alyssa R. Golden, Margot Rosenthal, et al. · Journal of Antimicrobial Chemotherapy · 75
PDF
Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007–2009 study
2011 · George G. Zhanel, Heather J. Adam, et al. · Diagnostic Microbiology and Infectious Disease · 75
Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997–2006
2009 · Heather J. Adam, Daryl J. Hoban, et al. · International Journal of Antimicrobial Agents · 74
In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014–2015
2017 · George G. Zhanel, Melanie R. Baxter, et al. · Diagnostic Microbiology and Infectious Disease · 72
42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study
2019 · George G Zhanel, Heather J Adam, et al. · Journal of Antimicrobial Chemotherapy · 68
Works count: 183
Citation count: 7,654
H-index: 45
I10-index: 111
Year
Topic
Type